China Medical System Holdings Ltd. engages in the production, marketing, promotion, and sale of drugs. The company employs 6,141 full-time employees The company went IPO on 2010-09-28. The firm's products include Plendil, Ursofalk, Augentropfen Stulln Mono Eye Drops, Hirudoid, Atopic Piel Series and Vmonalisa, among others. Its major marketed products cover the cardio-cerebrovascular, gastroenterology, ophthalmology, dermatology and medical aesthetic fields. The firm distributes its products within domestic market and to overseas markets.
Follow-Up Questions
What is the price performance of CHSYF stock?
The current price of CHSYF is $0, it has decreased 0% in the last trading day.
What are the primary business themes or industries for China Medical System Holdings Ltd?
China Medical System Holdings Ltd belongs to Pharmaceuticals industry and the sector is Health Care
What is China Medical System Holdings Ltd market cap?
China Medical System Holdings Ltd's current market cap is $0
Is China Medical System Holdings Ltd a buy, sell, or hold?
According to wall street analysts, 7 analysts have made analyst ratings for China Medical System Holdings Ltd, including 2 strong buy, 7 buy, 2 hold, 0 sell, and 2 strong sell
